BIOMAT Database Logo BIOMAT Database Logo

[Rifampicin in staphylococcal infections]. 1982

V Arioli

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

V Arioli
The use of rifampicin in staphylococcal infections--a review.
June 1984, The Journal of antimicrobial chemotherapy,
V Arioli
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
August 2023, International journal of antimicrobial agents,
V Arioli
[Netilmicin and netilmicin-rifampicin combination in targeted treatment of staphylococcal infections].
September 1986, La Clinica terapeutica,
V Arioli
Treatment of severe staphylococcal infections with a rifampicin-minocycline association.
June 1984, The Journal of antimicrobial chemotherapy,
V Arioli
Open wounds and rifampicin therapy are associated with rifampicin resistance among staphylococcal vascular graft/endograft infections.
March 2021, JAC-antimicrobial resistance,
V Arioli
[Staphylococcal hospital infections. Staphylococcus carriers in the hospital environment. Their sterilization with rifampicin].
January 1970, Giornale di batteriologia, virologia, ed immunologia ed annali dell'Ospedale Maria Vittoria di Torino,
V Arioli
[Treatment of severe staphylococcal infections. Failure of rifampicin in combination therapy. 4 cases].
May 1985, Presse medicale (Paris, France : 1983),
V Arioli
A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections.
August 2010, The Journal of antimicrobial chemotherapy,
V Arioli
[Rifampicin in the treatment of staphylococcal infection].
August 1986, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
V Arioli
Efficacy of a combined oral clindamycin?rifampicin regimen for therapy of staphylococcal osteoarticular infections.
December 2011, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!